FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer
The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
May 11, 2026
0
4
MeSH tree: C19.344
The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
May 11, 2026
0
4
Researchers at the University of Cincinnati Gardner Neuroscience Institute's Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy ...
May 4, 2026
0
29
New research shows that palliative patients with pancreatic cancer neither live longer nor experience improved quality of life when taking mistletoe extract in addition to standard cancer treatment, compared to placebo. The ...
May 4, 2026
0
3
Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study ...
May 3, 2026
0
13
Scientists at The Wistar Institute and clinical researchers from ChristianaCare's Helen F. Graham Cancer Center & Research Institute have discovered a vulnerability in pancreatic cancer that could be targeted as a potential ...
May 3, 2026
0
29
Scientists at Oregon Health & Science University have developed a new technique using an electronic jolt and nanoparticles to reveal the telltale signal of an insidious form of cancer.
May 2, 2026
0
10
Researchers at Trinity College Dublin have published a major new review that brings fresh clarity to one of the deadliest forms of cancer—pancreatic cancer—by mapping how the disease operates at every level. The review is ...
May 1, 2026
0
14
A new scoping review from the University of Toronto reveals that caregivers of loved ones with ovarian cancer face significant emotional strain, heavy caregiving responsibilities, and limited support throughout the disease ...
Apr 30, 2026
0
3
Pancreatic cancer can remain quiet for years, developing undetected before causing symptoms that lead to a diagnosis. Even after a surgeon removes a pancreas tumor, other cells often hide and erupt later. But University of ...
Apr 30, 2026
0
17
Research conducted at the National Cancer Research Centre (CNIO) has revealed an unexpected behavior observed in a protein involved in several types of cancer: it manages to self-activate, meaning it gives itself the order ...
Apr 29, 2026
0
6